Artículos por temáticas

Impact of the FindMyApps program on people with mild cognitive impairment or dementia and their caregivers; an exploratory pilot randomised controlled trial

Beentjes KM, Neal DP, Kerkhof YJF, Broeder C, Moeridjan ZDJ, Ettema TP, Pelkmans W, Muller MM, Graff MJL, Dröes RM.

Disabil Rehabil Assist Technol. 2023 Apr;18(3):253-265. doi: 10.1080/17483107.2020.1842918. Epub 2020 Nov 27.

Acupressure and Dementia: A Review of Current Evidence

Liang Ooi S, Drew G, Cheon Pak S.

Altern Ther Health Med. 2023 Oct;29(7):18-29.

Analysis of the risk factors of mortality in elderly patients with hip fracture using a combined database of medical and long-term care insurance claims data

Takagi K, Matsugaki R, Fujimoto K, Mine Y, Muramatsu K, Fujino Y, Matsuda S.

J Orthop Sci. 2023 May;28(3):627-630. doi: 10.1016/j.jos.2022.01.009. Epub 2022 Feb 3.

Elevated sTREM2 and NFL levels in patients with sepsis associated encephalopathy

Orhun G, Esen F, Yilmaz V, Ulusoy C, Şanlı E, Yıldırım E, Gürvit H, Ergin Özcan P, Sencer S, Bebek N, Tüzün E.

Int J Neurosci. 2023 Mar;133(3):327-333. doi: 10.1080/00207454.2021.1916489. Epub 2021 May 4.

White matter hyperintensities and longitudinal cognitive decline in cognitively normal populations and across diagnostic categories: A meta-analysis, systematic review, and recommendations for future study harmonization

Roseborough AD, Saad L, Goodman M, Cipriano LE, Hachinski VC, Whitehead SN.

Alzheimers Dement. 2023 Jan;19(1):194-207. doi: 10.1002/alz.12642. Epub 2022 Mar 23.

Effects and mechanisms of natural products on Alzheimer's disease

Yang Z, Zhou DD, Huang SY, Fang AP, Li HB, Zhu HL.

Crit Rev Food Sci Nutr. 2023;63(18):3168-3188. doi: 10.1080/10408398.2021.1985428. Epub 2021 Oct 6.

Identifying best practices for disclosure of amyloid imaging results: A randomized controlled trial

Fruijtier AD, van der Schaar J, van Maurik IS, Zwan MD, Scheltens P, Bouwman F, Pijnenburg YAL, van Berckel BNM, Ebenau J, van der Flier WM, Smets EMA, Visser LNC.

Alzheimers Dement. 2023 Jan;19(1):285-295. doi: 10.1002/alz.12630. Epub 2022 Apr 2.

Effect of reduction in brain amyloid levels on change in cognitive and functional decline in randomized clinical trials: An instrumental variable meta-analysis

Pang M, Zhu L, Gabelle A, Gafson AR, Platt RW, Galvin JE, Krolak-Salmon P, Rubino I, de Moor C, Belachew S, Shen C.

Alzheimers Dement. 2023 Apr;19(4):1292-1299. doi: 10.1002/alz.12768. Epub 2022 Aug 31.

Successful aging after elective surgery II: Study design and methods

Hshieh TT, Schmitt EM, Fong TG, Arnold S, Cavallari M, Dickerson BC, Dillon ST, Jones RN, Libermann TA, Marcantonio ER, Pascual-Leone A, Shafi MM, Touroutoglou A, Travison TG, Gou RY, Tommet D, Abdeen

J Am Geriatr Soc. 2023 Jan;71(1):46-61. doi: 10.1111/jgs.18065. Epub 2022 Oct 10.

Reduced synaptic proteins and SNARE complexes in Down syndrome with Alzheimer's disease and the Dp16 mouse Down syndrome model: Impact of APP gene dose

Chen XQ, Zuo X, Becker A, Head E, Mobley WC.

Alzheimers Dement. 2023 May;19(5):2095-2116. doi: 10.1002/alz.12835. Epub 2022 Nov 12.

Subjective cognitive decline and stage 2 of Alzheimer disease in patients from memory centers

Jessen F, Wolfsgruber S, Kleineindam L, Spottke A, Altenstein S, Bartels C, Berger M, Brosseron F, Daamen M, Dichgans M, Dobisch L, Ewers M, Fenski F, Fliessbach K, Freiesleben SD, Glanz W, Görß D, Gü

Alzheimers Dement. 2023 Feb;19(2):487-497. doi: 10.1002/alz.12674. Epub 2022 Apr 22.

Identification through the Manchester Triage System of the older population at risk of delirium: A case-control study

Soler-Sanchis A, Martínez-Arnau FM, Sánchez-Frutos J, Pérez-Ros P.

J Clin Nurs. 2023 Jun;32(11-12):2642-2651. doi: 10.1111/jocn.16349. Epub 2022 May 12.

Technology for activity participation in older people with mild cognitive impairment or dementia: expert perspectives and a scoping review

Schepens Niemiec SL, Lee E, Saunders R, Wagas R, Wu S.

Disabil Rehabil Assist Technol. 2023 Nov;18(8):1555-1576. doi: 10.1080/17483107.2022.2116114. Epub 2022 Sep 6.

Mechanisms and Clinical Manifestations of Cognitive Decline in Atrial Fibrillation Patients: Potential Implications for Preventing Dementia

Blum S, Conen D.

Can J Cardiol. 2023 Feb;39(2):159-171. doi: 10.1016/j.cjca.2022.10.013. Epub 2022 Oct 15.

A Randomised Placebo-Controlled Study of Purified Anthocyanins on Cognition in Individuals at Increased Risk for Dementia

Aarsland D, Khalifa K, Bergland AK, Soennesyn H, Oppedal K, Holteng LBA, Oesterhus R, Nakling A, Jarholm JA, de Lucia C, Fladby T, Brooker H, Dalen I, Ballard C.

Am J Geriatr Psychiatry. 2023 Feb;31(2):141-151. doi: 10.1016/j.jagp.2022.10.002. Epub 2022 Oct 18.